Literature DB >> 20618464

Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy.

Madalene C Y Heng1.   

Abstract

Photocarcinogenesis is caused by DNA damage from solar radiation in the ultraviolet range, resulting in the development of both melanoma and non-melanoma skin cancers. Although the ultraviolet B (UVB) spectrum has previously been considered the more carcinogenic of the two, recent evidence suggests that ultraviolet A (UVA) irradiation may have damaging effects that are not generally appreciated. Furthermore, it is becoming apparent that although sunscreens have been in use for many years, they are relatively ineffective in protecting against UVA-induced photoaging and UVA-induced skin cancers. More recently, attention has been directed on certain dietary phytochemicals, in particular curcumin, in the attempt to repair photodamaged skin as a means of preventing degeneration into solar-induced skin cancers. Curcumin has been shown to protect against the deleterious effects of injury by attenuating oxidative stress and suppressing inflammation. In this review, the curcumin-targeted signaling pathways directed against solar-induced injury are reviewed. The ability of curcumin to block multiple targets on these pathways serve as a basis for the potential use of this phytochemical in photoaging skin and photocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618464     DOI: 10.1111/j.1365-4632.2010.04468.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  13 in total

1.  Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells.

Authors:  N M Rogers; M D Stephenson; A R Kitching; J D Horowitz; P T H Coates
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Botanicals for the prevention and treatment of cutaneous melanoma.

Authors:  Deeba N Syed; Hasan Mukhtar
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-12       Impact factor: 4.693

3.  Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial.

Authors:  Julie Ryan Wolf; Jennifer S Gewandter; Javier Bautista; Charles E Heckler; Jon Strasser; Pawal Dyk; Thomas Anderson; Howard Gross; Tod Speer; Lindsey Dolohanty; Kevin Bylund; Alice P Pentland; Gary R Morrow
Journal:  Support Care Cancer       Date:  2019-11-22       Impact factor: 3.603

Review 4.  Chemoprevention of melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Adv Pharmacol       Date:  2012

5.  The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition.

Authors:  Xiaofei Wang; Yan Zhang; Xiwen Zhang; Wenxia Tian; Wenli Feng; Tingmei Chen
Journal:  Int J Oncol       Date:  2011-12-14       Impact factor: 5.650

6.  Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Chin Med       Date:  2011-08-23       Impact factor: 5.455

7.  Curcuminoid binding to embryonal carcinoma cells: reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation.

Authors:  Wolfgang W Quitschke
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

Review 8.  Plant derived substances with anti-cancer activity: from folklore to practice.

Authors:  Marcelo Fridlender; Yoram Kapulnik; Hinanit Koltai
Journal:  Front Plant Sci       Date:  2015-10-01       Impact factor: 5.753

9.  Discovering the link between nutrition and skin aging.

Authors:  Silke K Schagen; Vasiliki A Zampeli; Evgenia Makrantonaki; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2012-07-01

10.  Curcumin protects human keratinocytes against inorganic arsenite-induced acute cytotoxicity through an NRF2-dependent mechanism.

Authors:  Rui Zhao; Bei Yang; Linlin Wang; Peng Xue; Baocheng Deng; Guohua Zhang; Shukun Jiang; Miao Zhang; Min Liu; Jingbo Pi; Dawei Guan
Journal:  Oxid Med Cell Longev       Date:  2013-04-21       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.